Pathogenesis of hypertrophic cardiomyopathy caused by myozenin 2 mutations is independent of calcineurin activity
about
Mutations in filamin C cause a new form of familial hypertrophic cardiomyopathyMolecular cloning and characterization of different expression of MYOZ2 and MYOZ3 in Tianfu goat.Immunohistochemical detection of FLAG-tagged endogenous proteins in knock-in mice.Gene Expression in Experimental Aortic Coarctation and Repair: Candidate Genes for Therapeutic Intervention?Cardiac Fibro-Adipocyte Progenitors Express Desmosome Proteins and Preferentially Differentiate to Adipocytes Upon Deletion of the Desmoplakin Gene.Proteomic and metabolomic changes driven by elevating myocardial creatine suggest novel metabolic feedback mechanismsThe hippo pathway is activated and is a causal mechanism for adipogenesis in arrhythmogenic cardiomyopathy.Genetic anticipation in a special form of hypertrophic cardiomyopathy with sudden cardiac death in a family with 74 members across 5 generations.Genetic testing for inherited cardiac disease.Animal Models of Congenital Cardiomyopathies Associated With Mutations in Z-Line Proteins.Defining the genetic architecture of hypertrophic cardiomyopathy: re-evaluating the role of non-sarcomeric genes.Overview of the Muscle Cytoskeleton.A One Health Approach to Hypertrophic Cardiomyopathy.Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy.Suppression of Activated FOXO Transcription Factors in the Heart Prolongs Survival in a Mouse Model of Laminopathies.Distinct Cellular Basis for Early Cardiac Arrhythmias, the Cardinal Manifestation of Arrhythmogenic Cardiomyopathy, and the Skin Phenotype of Cardiocutaneous Syndromes.Extracellular visfatin has nicotinamide phosphoribosyltransferase enzymatic activity and is neuroprotective against ischemic injury.Myocyte enhancer factor 2A promotes proliferation and its inhibition attenuates myogenic differentiation via myozenin 2 in bovine skeletal muscle myoblast.
P2860
Q28115580-CD8B8CCD-BC77-4A80-90D8-CE193E344DCDQ35075329-48123805-03BD-4474-810F-DC4B958A305FQ35217897-6B27E3F8-470C-4356-8E82-2B79210CECA8Q35710931-016E24B8-C4CC-47FB-9825-F25FAC028321Q37037380-A705BC9F-5D45-4551-8186-55743092FF69Q37153408-795F9F44-12E7-4482-9B30-B1A3B2E59E8CQ37624877-864335B0-96CE-4F52-A817-401EE22C3D49Q37725295-6045937A-29EE-4E18-B1C7-B1C24151F213Q38125385-914516A2-15E2-4F1E-8592-63CC3DCA6D3EQ38832827-2EC5F07C-8153-438D-8B53-B36A292C5635Q39023719-BD710A2F-CE54-4CF6-A3FD-D1E3E5067E58Q39391006-94BEA316-414E-401C-BD30-8507B778F864Q41687674-1FC0A0F0-6A5F-4351-ADEB-F37BCC6E7038Q42515078-CDC3ECB5-B76C-472C-998B-64DB37F09678Q47215949-6BF7949A-9798-4CBF-A085-0C3D9CB1DD55Q47669391-F77CB9A6-92F1-412C-87E2-DEBD696041EDQ51728725-87DA717E-3349-4BED-9462-67539BF27E5DQ52561235-822B7398-872C-4849-AE67-34E2E8D44108
P2860
Pathogenesis of hypertrophic cardiomyopathy caused by myozenin 2 mutations is independent of calcineurin activity
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Pathogenesis of hypertrophic c ...... endent of calcineurin activity
@ast
Pathogenesis of hypertrophic c ...... endent of calcineurin activity
@en
type
label
Pathogenesis of hypertrophic c ...... endent of calcineurin activity
@ast
Pathogenesis of hypertrophic c ...... endent of calcineurin activity
@en
prefLabel
Pathogenesis of hypertrophic c ...... endent of calcineurin activity
@ast
Pathogenesis of hypertrophic c ...... endent of calcineurin activity
@en
P2093
P2860
P356
P1476
Pathogenesis of hypertrophic c ...... endent of calcineurin activity
@en
P2093
Ali J Marian
Gabriela Rodriguez
Suet Nee Chen
P2860
P356
10.1093/CVR/CVS294
P577
2012-09-17T00:00:00Z